ATE392152T1 - Coenzym q10 formulierungen - Google Patents

Coenzym q10 formulierungen

Info

Publication number
ATE392152T1
ATE392152T1 AT03702603T AT03702603T ATE392152T1 AT E392152 T1 ATE392152 T1 AT E392152T1 AT 03702603 T AT03702603 T AT 03702603T AT 03702603 T AT03702603 T AT 03702603T AT E392152 T1 ATE392152 T1 AT E392152T1
Authority
AT
Austria
Prior art keywords
coenzyme
formulations
matrix
droplets
gelatin
Prior art date
Application number
AT03702603T
Other languages
English (en)
Inventor
Chyi-Chen Chen
Bruno Leuenberger
Johann Ulm
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE392152T1 publication Critical patent/ATE392152T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Soft Magnetic Materials (AREA)
  • Lubricants (AREA)
AT03702603T 2002-02-14 2003-02-06 Coenzym q10 formulierungen ATE392152T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02003433 2002-02-14

Publications (1)

Publication Number Publication Date
ATE392152T1 true ATE392152T1 (de) 2008-05-15

Family

ID=27675622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03702603T ATE392152T1 (de) 2002-02-14 2003-02-06 Coenzym q10 formulierungen

Country Status (9)

Country Link
US (1) US20050142123A1 (de)
EP (1) EP1476032B1 (de)
JP (1) JP2005517031A (de)
CN (1) CN1633245A (de)
AT (1) ATE392152T1 (de)
AU (1) AU2003205738A1 (de)
DE (1) DE60320380T2 (de)
ES (1) ES2302913T3 (de)
WO (1) WO2003068008A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3031283A1 (en) 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use
BRPI0611526A2 (pt) * 2005-05-19 2009-11-24 Aqua Bio Technology Asa composição tópica contendo gelatina
ES2369928T3 (es) * 2005-06-29 2011-12-09 Dsm Ip Assets B.V. Nanopartículas de isoflavonas y su utilización.
CN101272769B (zh) * 2005-07-28 2013-04-24 Isp投资有限公司 生物利用度提高的苯醌类化合物
WO2007014392A2 (en) * 2005-07-28 2007-02-01 Isp Investments Inc. Benzoquinones of enhanced bioavailability
WO2007014566A2 (en) * 2005-08-04 2007-02-08 Basf Aktiengesellschaft Microcapsules and their use
JP2007161656A (ja) * 2005-12-15 2007-06-28 Arimino Kagaku Kk 毛髪化粧料
US20070184040A1 (en) * 2006-02-06 2007-08-09 Clouatre Dallas L Compositions for delivery of coenzyme Q10
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
US8613946B2 (en) 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
US10189957B2 (en) 2007-01-26 2019-01-29 Isp Investments Llc Formulation process method to produce spray dried products
MX363435B (es) 2007-03-22 2019-03-22 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
US20100092560A1 (en) * 2007-04-16 2010-04-15 Kaneka Corporation Reduced coenzyme q10-containing particulate composition and method for producing the same
CN101288641B (zh) * 2007-04-19 2012-07-11 浙江一新制药股份有限公司 辅酶q10水分散体及其制备方法
PL2173321T3 (pl) * 2007-07-19 2025-04-28 Dsm Ip Assets B.V. Tabletkowane formulacje lipofilowych składników zdrowotnych
AU2009233785B2 (en) 2008-04-11 2015-08-20 Berg Llc Methods and use of inducing apoptosis in cancer cells
KR101016741B1 (ko) 2008-07-16 2011-02-25 재단법인서울대학교산학협력재단 유비데카레논-함유 고체분산체의 제조방법
BRPI1010576A2 (pt) 2009-05-11 2016-03-15 Berg Biosystems Llc métodos para tratamento de distúrbios oncológicos usando transferidores epimetabólicos, moléculas intracelulares multidimensionais ou influenciadores ambientais.
PT2544663T (pt) 2010-03-12 2018-04-05 Berg Llc Formulações intravenosas de coenzima q10 (coq10) e métodos de uso da mesma
CN102258473B (zh) * 2010-05-24 2013-03-13 富阳科兴生物化工有限公司 自微乳型辅酶q10粉状干乳及其应用
CN102258474B (zh) * 2010-05-24 2012-10-10 富阳科兴生物化工有限公司 自微乳型辅酶q10粉状干乳的制备方法
EP2694463B8 (de) 2011-04-04 2019-10-09 Berg LLC Behandlung von tumoren im zentralnervensystem mit coenzym q10
AU2012271274B2 (en) 2011-06-17 2017-07-27 Berg Llc Inhalable pharmaceutical compositions
JP6065585B2 (ja) * 2012-12-28 2017-01-25 ユーハ味覚糖株式会社 ガレート型カテキン含有化粧料
SG11201508272YA (en) 2013-04-08 2015-11-27 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
JP6595478B2 (ja) 2013-09-04 2019-10-23 バーグ エルエルシー コエンザイムｑ１０の連続注入によるがんの治療方法
JP6287123B2 (ja) * 2013-11-29 2018-03-07 ユーハ味覚糖株式会社 ユビキノール含有液状組成物
EP3193629B1 (de) * 2014-08-25 2023-01-25 Anatara Lifesciences Limited Formulierung gegen durchfall mit verhinderung von antimikrobieller resistenz
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN110200910B (zh) * 2019-06-17 2022-04-19 北京中超海奇科技有限公司 一种辅酶q10透明水分散液的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951214A (ja) * 1982-09-16 1984-03-24 Taiho Yakuhin Kogyo Kk バイオアベイラビリテイの高い薬剤の製造方法
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
US5284674A (en) * 1992-05-11 1994-02-08 Fazio Susan C Powdered dairy creamer
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
DE69935946T2 (de) * 1998-06-24 2007-09-06 Dsm Ip Assets B.V. Vitaminpulver zur verwendung für getränke
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020103139A1 (en) * 2000-12-01 2002-08-01 M. Weisspapir Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control

Also Published As

Publication number Publication date
DE60320380T2 (de) 2009-05-20
CN1633245A (zh) 2005-06-29
EP1476032A1 (de) 2004-11-17
US20050142123A1 (en) 2005-06-30
AU2003205738A1 (en) 2003-09-04
EP1476032B1 (de) 2008-04-16
DE60320380D1 (de) 2008-05-29
JP2005517031A (ja) 2005-06-09
WO2003068008A1 (en) 2003-08-21
ES2302913T3 (es) 2008-08-01

Similar Documents

Publication Publication Date Title
ATE392152T1 (de) Coenzym q10 formulierungen
HUS2000011I1 (hu) A 2,4-pirimidin-diamin vegyületek elõgyógyszerei és alkalmazásuk
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
BRPI0616071B8 (pt) métodos de revestir uma micropartícula cristalina pré-formada em suspensão com um agente ativo
EA200701246A1 (ru) Стабильные при комнатной температуре составы дронабинола
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
MXPA05007328A (es) Composiciones que contienen agentes antiacne y el uso de las mismas.
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
ATE399467T1 (de) Komprimierte harz-moderierte kaugummi
PA8604401A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
DE50204688D1 (de) N-alkylaziridinoprepolymere als dentalmasse
SV2007002422A (es) Derivados del (1,5-difenil-1h-pirazol-3-il)oxadiazol, su preparacion y su aplicacion en terapeutica.
BR0311347A (pt) Alcanóis bis-aromáticos
ATE478125T1 (de) Reversible thermochromische zusammensetzungen
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
DE602006011275D1 (de) Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat
GT200400134A (es) Sistemas emulsionantes que contienen derivados de azetidina
DE60315711D1 (de) Aliphatische polyesterharz-zusammensetzung
EA200400343A1 (ru) Композиция с контролируемым высвобождением кларитромицина или тинидазола
BRPI0500536A (pt) Composição antimicrobiana
ATE455471T1 (de) Pulverförmige zusammensetzungen von fettlöslichen substanzen
ATE350025T1 (de) Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel
TW200724152A (en) Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties